Cost-effectiveness Analysis of Four Different Drugs for Benign Prostatic Hypertrophy / 中国药房
China Pharmacy
;
(12)2001.
Artículo
en Chino
| WPRIM
| ID: wpr-517866
ABSTRACT
AIM:
To evaluate the economic effectiveness of different therapeutic schemes for benign prostatic hypertrophyMETHODS:
175 patients with benign prostatic hypertrophy were divided into 4 groupsA,B,C and D They received different drugs,Atamsulosin(34),Bprostat(45),Ctedenan(46) and Dqiangliexin(50)RESULTS:
The costs of A,B,C,D schemes were RMB 492 80,499 52,526 40 and 664 16 yuans,respectively,and the effective ratios were 85 3%,82 2%,80 4% and 80 0%,respectivelyCONCLUSION:
According to the evaluation with pharmacoeconomic cost-effectiveness analysis,A is the best scheme
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Evaluación Económica en Salud
Idioma:
Chino
Revista:
China Pharmacy
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS